Prevalence and associated factors of scabies among school going children in Khulna division: a comparative cross-sectional study between schools and madrasahs (Islamic religious schools) - Top-Institutions - MDSpire

Prevalence and associated factors of scabies among school going children in Khulna division: a comparative cross-sectional study between schools and madrasahs (Islamic religious schools)

  • By

  • Md Mothashin

  • Mahir Hossain Labib

  • Abu Sayed Md Al Mamun

  • Md Golam Hossain

  • May 22, 2026

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    Murdoch Children’s Research Institute
    Murdoch Children’s Research Institute

    Melbourne, Victoria

    Key Differentiators

    • Pediatrics
    • Tropical Diseases

  • #2

    Telethon Kids Institute
    Telethon Kids Institute

    Perth, Western Australia

    Key Differentiators

    • Pediatrics
    • Infectious Diseases

  • #3

    Health and Demographic Surveillance site in Iganga and Mayuge Districts
    Health and Demographic Surveillance site in Iganga and Mayuge Districts

    Iganga, Uganda

    Key Differentiators

    • Public Health
    • Epidemiology

  • #4

    Butabika National Referral Hospital
    Butabika National Referral Hospital

    Kampala, Uganda

    Key Differentiators

    • Mental Health
    • Pediatrics

  • #5

    Manhiça District Hospital
    Manhiça District Hospital

    Manhiça, Mozambique

    Key Differentiators

    • Pediatrics
    • Infectious Diseases

Original Source(s)

Prevalence and associated factors of scabies among school going children in Khulna division: a comparative cross-sectional study between schools and madrasahs (Islamic religious schools)

  • by Md Mothashin, Mahir Hossain Labib, Abu Sayed Md Al Mamun, Md Golam Hossain

  • May 22, 2026

Related Content

Agentic AI system may improve rare disease diagnosis 

Higher diagnostic accuracy seen in endocrine system disorders and multisystem conditions.

FDA Clears Self-Administered Lupus Therapy

Once-weekly autoinjector approval was based on Phase 3 data, with safety consistent with intravenous administration.

Clinical and dermoscopic analysis of 32 cases of acquired facial hyperpigmented macules